首页> 美国卫生研究院文献>Gynecologic Oncology Case Reports >Pelvic exenteration by robotically-assisted laparoscopy: A feasibility series of 6 cases
【2h】

Pelvic exenteration by robotically-assisted laparoscopy: A feasibility series of 6 cases

机译:机器人腹腔镜下盆腔引流术:6例可行性研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

After concomitant chemo-radiation therapy, 20 to 30% of advanced cervical cancers recur in irradiated territory. Pelvic exenteration remains a therapeutic option for selected patients. However, this procedure remains complex because of tissue fragility after radiotherapy and their associated co-morbidities. Minimally invasive surgery such as robotically assisted laparoscopy may overcome these surgical challenges. The objective of this study was to evaluate the feasibility of pelvic exenteration with robotically assisted laparoscopy.Patients who underwent this procedure between 2015 and 2016 were included. Patients characteristics, treatment indication, intraoperative events, immediate and late complications, and histological outcomes were recorded.The data of 6 patients were analyzed. The primary cancer staging ranged from IB1 to IIB. All cases were loco-regional recurrence and 2 cases presented with with vesico-vaginal fistula. All patients had a history of pelvic irradiation. The mean operative time was 6.7 h. No complications occurred during surgery. The average hospital stay was 11.5 days. Immediate complications were mostly represented by urinary tract infections (4/5). Histological margins were clear in 67% (4/6), and a focal involvement was found in 33% (2/6) of cases. Late complications occurred within 82 days on average and included stenosis of ileal anastomosis, wound infection, acute renal failure, and pulmonary embolism. Revision surgery was necessary in 2 cases. There were 3 local recurrences occurring within an average of 215 days.In the light of these results, pelvic exenteration by robotically assisted laparoscopy may represent a valuable treatment modality of recurrent cervical cancer with low immediate postoperative morbidity.
机译:伴随化学放射治疗后,有20%至30%的晚期宫颈癌会在受辐照的地区复发。对于某些患者,盆腔引流仍然是一种治疗选择。然而,由于放疗后的组织脆弱性及其相关的合并症,该过程仍然很复杂。诸如机器人辅助腹腔镜之类的微创手术可以克服这些手术挑战。这项研究的目的是评估机器人辅助腹腔镜下盆腔引流术的可行性.2015年至2016年间接受该手术的患者也包括在内。记录患者的特征,治疗适应症,术中事件,即刻和晚期并发症以及组织学结果。分析6例患者的数据。原发癌分期从IB1到IIB。所有病例均为局部复发,2例伴有阴道阴道瘘。所有患者都有骨盆照射史。平均手术时间为6.7 h。手术期间无并发症发生。平均住院天数为11.5天。立即并发症主要表现为尿路感染(4/5)。组织学上的切缘在67%(4/6)中很明显,在33%(2/6)的病例中发现了局部受累。晚期并发症平均发生在82天之内,包括回肠吻合口狭窄,伤口感染,急性肾衰竭和肺栓塞。 2例需要进行翻修手术。在平均215天之内发生3例局部复发。根据这些结果,机器人辅助腹腔镜检查盆腔引流可能是复发性宫颈癌的一种有价值的治疗方式,术后立即发病率低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号